RESPOND Publications

Sep. 2025

A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND)

Levengood TW, Shaw LC, Zang X, Schackman BR, Walley AY, Urquhart C, Green TC, Chatterjee A, Marshall BDL, Morgan JR

Drug Alcohol Depend

You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears

Morgan JR, Walley AY

Addiction

Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids

Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP

JAMA Netw Open.

Empirical calibration of a simulation model of opioid use disorder

Madushani RWMA, Wang J, Weitz M, Linas BP, White LF, Chrysanthopoulou SA

PLoS One

Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States

Xiao Zang, Alexandra Skinner, Zongbo Li, Leah C Shaw, Czarina N Behrends, Avik Chatterjee, Ali Jalali, Ashly E Jordan, Jake R Morgan, Shayla Nolen, Bruce R Schackman, Brandon D L Marshall, Alexander Y Walley

Addiction

Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts

Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP

JAMA Netw Open.

Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis

Paul J Christine, Anna L Goldman, Jake R Morgan, Shapei Yan, Avik Chatterjee, Amy L Bettano, Ingrid A Binswanger, Marc R LaRochelle

JAMA Health Forum.

Medicaid-Covered Peer Support Services Used by Enrollees With Opioid Use Disorder

Bao Y, Zhang H, Hutchings K, Harris RA, Calderbank T, Schackman BR

JAMA Netw Open.

The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US

Christina E Freibott, Ali Jalali, Sean M Murphy, Alexander Y Walley, Benjamin P Linas, Philip J Jeng, Jeffrey Bratberg, Brandon D L Marshall, Xiao Zang, Traci C Green, Jake R Morgan

J Am Pharm Assoc

Out-of-pocket spending and health care utilization associated with initiation of different medications for opioid use disorder: Findings from a national commercially insured cohort

McCann NC, LaRochelle MR, Morgan JR

J Subst Use Addict Treat

The limits of innovation: Directly addressing known challenges is necessary to improve the real-world experience of novel medications for opioid use disorder

Jake R Morgan, Sabrina A Assoumou

Acad Emerg Med.

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder

Juliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, Alexandra Savinkina, Bruce R Schackman, Jianing Wang, R W M A Madushani, Jake R Morgan, Joshua A Barocas, Alexander Y Walley, Stavroula A Chrysanthopoulou, Benjamin P Linas, Sabrina A Assoumou

JAMA Netw Open.

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts

Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, Alexandria Macmadu, R W M A Madushani, Ruth A Potee, Danielle Ryan, Sean M Murphy, Alexander Y Walley, Benjamin P Linas

JAMA Netw Open.

Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

Allison R David, Carlos R Sian, Christina M Gebel, Benjamin P Linas, Jeffrey H Samet, Linda S Sprague Martinez, Jordana Muroff, Judith A Bernstein, Sabrina A Assoumou

J Subst Abuse Treat.

Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees

Jake R Morgan, Sean M Murphy, Sabrina A Assoumou, Benjamin P Linas

J Occup Environ Med.

Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs

Joëlla W Adams, Alexandra Savinkina, Aaron Fox, Czarina N Behrends, Rajapaksha W M A Madushani, Jianing Wang, Avik Chatterjee, Alexander Y Walley, Joshua A Barocas, Benjamin P Linas

Addiction.

Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder

Max Jordan Nguemeni Tiako, Angelica Meinhofer, Ari Friedman, Eugenia C South, Rachel L Epstein, Zachary F Meisel, Jake R Morgan

Am J Obstet Gynecol.

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City

Jake R Morgan, Christina E Freibott, Ali Jalali, Philip J Jeng, Alexander Y Walley, Avik Chatterjee, Traci C Green, Michelle L Nolan, Benjamin P Linas, Brandon D L Marshall, Sean M Murphy

Drug Alcohol Depend Rep.

Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis

Alexandra Savinkina, Rajapaksha W M A Madushani, Golnaz Eftekhari Yazdi, Jianing Wang, Joshua A Barocas, Jake R Morgan, Sabrina A Assoumou, Alexander Y Walley, Benjamin P Linas, Sean M Murphy

Addiciton.

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder

Tabatabaeepour N, Morgan JR, Jalali A, Kapadia SN, Meinhofer A

J Subst Abuse Treat

Health harms of non-medical prescription opioid use: A systematic review

Werb D, Scheim AI, Soipe A, Aeby S, Rammohan I, Fischer B, Hadland SE, Marshall BDL

Drug Alcohol Rev

Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder

Kimmel SD, Rosenmoss S, Bearnot B, Weinstein Z, Yan S, Walley AY, Larochelle MR

Health Aff (Millwood)

Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design

Jake R Morgan, Emily K Quinn, Christine E Chaisson, Elizabeth Ciemins, Nikita Stempniewicz, Laura F White, Benjamin P Linas, Alexander Y Walley, Marc R LaRochelle

Med Care.

Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder

Jake R Morgan, Emily K Quinn, Christine E Chaisson, Elizabeth Ciemins, Nikita Stempniewicz, Laura F White, Marc R Larochelle

J Subst Abuse Treat.

Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts

Avik Chatterjee, Shapei Yan, Ziming Xuan, Katherine M Waye, Audrey M Lambert, Traci C Green, Thomas J Stopka, Robin A Pollini, Jake R Morgan, Alexander Y Walley

Drug Alcohol Depend.

Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study

Barocas JA, Savinkina A, Adams J, Jawa R, Weinstein ZM, Samet JH, Linas BP

Lancet Public Health

Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study

Barocas JA, Eftekhari Yazdi G, Savinkina A, Nolen S, Savitzky C, Samet JH, Englander H, Linas BP

Clin Infect Dis

Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort

Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA

Drug Alcohol Depend

Projected Estimates of Opioid Mortality After Community-Level Interventions

Linas BP, Savinkina A, Madushani RWMA, Wang J, Eftekhari Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA

JAMA Netw Open.

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting

Morgan JR, Barocas JA, Murphy SM, Epstein RL, Stein MD, Schackman BR, Walley AY, Linas BP

JAMA Netw Open.

Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by Sex

Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Hadland SE, Barocas JA

JAMA Netw Open.

Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections

Barocas JA, Gai MJ, Amuchi B, Jawa R, Linas BP

Drug Alcohol Depend

Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis

Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, Weiss RD, Samet JH, Larochelle MR

JAMA Netw Open.

Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis

Kimmel SD, Walley AY, Linas BP, Kalesan B, Awtry E, Dobrilovic N, White L, LaRochelle M

Clin Infect Dis

Improving Outcomes for People With Injection Drug-related Endocarditis: Are Medications for Opioid Use Disorder Enough?

Kimmel SD, Del Rio C

J Addict Med

Opioid overdose and inpatient care for substance use disorder care in Massachusetts

Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP

J Subst Abuse Treat

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP

Drug Alcohol Depend

Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis

Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP

Am J Public Health

RESPOND Publications

Sep. 2025

A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND)

Levengood TW, Shaw LC, Zang X, Schackman BR, Walley AY, Urquhart C, Green TC, Chatterjee A, Marshall BDL, Morgan JR

June 2025

You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears

Morgan JR, Walley AY

June 2025

Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids

Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP

Mar. 2025

Empirical calibration of a simulation model of opioid use disorder

Madushani RWMA, Wang J, Weitz M, Linas BP, White LF, Chrysanthopoulou SA

Oct 2024

Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States

Xiao Zang, Alexandra Skinner, Zongbo Li, Leah C Shaw, Czarina N Behrends, Avik Chatterjee, Ali Jalali, Ashly E Jordan, Jake R Morgan, Shayla Nolen, Bruce R Schackman, Brandon D L Marshall, Alexander Y Walley

Oct. 2024

Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts

Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP

July 2024

Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis

Paul J Christine, Anna L Goldman, Jake R Morgan, Shapei Yan, Avik Chatterjee, Amy L Bettano, Ingrid A Binswanger, Marc R LaRochelle

July 2024

Medicaid-Covered Peer Support Services Used by Enrollees With Opioid Use Disorder

Bao Y, Zhang H, Hutchings K, Harris RA, Calderbank T, Schackman BR

Apr. 2024

The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US

Christina E Freibott, Ali Jalali, Sean M Murphy, Alexander Y Walley, Benjamin P Linas, Philip J Jeng, Jeffrey Bratberg, Brandon D L Marshall, Xiao Zang, Traci C Green, Jake R Morgan

Apr. 2024

Out-of-pocket spending and health care utilization associated with initiation of different medications for opioid use disorder: Findings from a national commercially insured cohort

McCann NC, LaRochelle MR, Morgan JR

Dec. 2023

The limits of innovation: Directly addressing known challenges is necessary to improve the real-world experience of novel medications for opioid use disorder

Jake R Morgan, Sabrina A Assoumou

Sep. 2023

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder

Juliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, Alexandra Savinkina, Bruce R Schackman, Jianing Wang, R W M A Madushani, Jake R Morgan, Joshua A Barocas, Alexander Y Walley, Stavroula A Chrysanthopoulou, Benjamin P Linas, Sabrina A Assoumou

Apr. 2023

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts

Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, Alexandria Macmadu, R W M A Madushani, Ruth A Potee, Danielle Ryan, Sean M Murphy, Alexander Y Walley, Benjamin P Linas

Nov 2022

Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

Allison R David, Carlos R Sian, Christina M Gebel, Benjamin P Linas, Jeffrey H Samet, Linda S Sprague Martinez, Jordana Muroff, Judith A Bernstein, Sabrina A Assoumou

Nov. 2022

Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees

Jake R Morgan, Sean M Murphy, Sabrina A Assoumou, Benjamin P Linas

Oct. 2022

Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs

Joëlla W Adams, Alexandra Savinkina, Aaron Fox, Czarina N Behrends, Rajapaksha W M A Madushani, Jianing Wang, Avik Chatterjee, Alexander Y Walley, Joshua A Barocas, Benjamin P Linas

Sep. 2022

Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder

Max Jordan Nguemeni Tiako, Angelica Meinhofer, Ari Friedman, Eugenia C South, Rachel L Epstein, Zachary F Meisel, Jake R Morgan

Sep. 2022

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City

Jake R Morgan, Christina E Freibott, Ali Jalali, Philip J Jeng, Alexander Y Walley, Avik Chatterjee, Traci C Green, Michelle L Nolan, Benjamin P Linas, Brandon D L Marshall, Sean M Murphy

Sep. 2022

Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis

Alexandra Savinkina, Rajapaksha W M A Madushani, Golnaz Eftekhari Yazdi, Jianing Wang, Joshua A Barocas, Jake R Morgan, Sabrina A Assoumou, Alexander Y Walley, Benjamin P Linas, Sean M Murphy

Sep. 2022

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder

Tabatabaeepour N, Morgan JR, Jalali A, Kapadia SN, Meinhofer A

May 2022

Health harms of non-medical prescription opioid use: A systematic review

Werb D, Scheim AI, Soipe A, Aeby S, Rammohan I, Fischer B, Hadland SE, Marshall BDL

Mar. 2022

Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder

Kimmel SD, Rosenmoss S, Bearnot B, Weinstein Z, Yan S, Walley AY, Larochelle MR

Mar. 2022

Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design

Jake R Morgan, Emily K Quinn, Christine E Chaisson, Elizabeth Ciemins, Nikita Stempniewicz, Laura F White, Benjamin P Linas, Alexander Y Walley, Marc R LaRochelle

Feb 2022

Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder

Jake R Morgan, Emily K Quinn, Christine E Chaisson, Elizabeth Ciemins, Nikita Stempniewicz, Laura F White, Marc R Larochelle

Jan. 2022

Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts

Avik Chatterjee, Shapei Yan, Ziming Xuan, Katherine M Waye, Audrey M Lambert, Traci C Green, Thomas J Stopka, Robin A Pollini, Jake R Morgan, Alexander Y Walley

Jan. 2022

Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study

Barocas JA, Savinkina A, Adams J, Jawa R, Weinstein ZM, Samet JH, Linas BP

Dec. 2021